Abstract
Recombinant erythropoietin is being used in premature population for anemia of prematurity. It is considered very safe in this population, although risks are still being evaluated. We report the first case of dermal erythropoiesis as a side effect of recombinant erythropoietin in an extremely prematurely born infant presenting with late-onset blueberry muffin lesions.
Original language | English (US) |
---|---|
Pages (from-to) | 534-535 |
Number of pages | 2 |
Journal | Journal of Pediatric Hematology/Oncology |
Volume | 34 |
Issue number | 7 |
DOIs | |
State | Published - Oct 2012 |
Externally published | Yes |
Keywords
- anemia of prematurity
- dermal erythropoiesis
- extramedullary hematopoiesis
- premature infant
- recombinant erythropoietin
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health
- Hematology
- Oncology